Platelets in Regeneration

 

 Buy Article Permissions and Reprints

ABSTRACT

Platelets, as the first cellular response after disruption of vascular and/or tissue integrity, cover any existing injury within our body. But is the regenerative potential of platelets limited to providing a cellular patch for wounds? This review highlights the recent advance in our understanding of platelets being distinctly regulated and regulating cells that contribute immensely to the healing process from the very initial stage to the late events of tissue regeneration. For instance, the intrinsic actions of platelets as a regenerative cell, the participation of platelets in angiogenic processes, and the interplay of platelets and circulating stem and progenitor cells, as well as potential therapeutic implications, are addressed. Although we are starting to understand the underlying mechanisms connecting platelets to the components of tissue regeneration just mentioned, many aspects remain to be elucidated. The demand to invest research in this area is underscored by the fact that platelets or platelet-derived molecules are already applied in clinical contexts such as connective tissue regeneration, whereas other research fields have largely neglected platelet effects going beyond their participation in the coagulation cascade. Understanding the mechanisms connecting platelets to tissue regeneration, however, will inevitably open novel options in regenerative medicine.

REFERENCES

• 1 Jackson S P. The growing complexity of platelet aggregation.  Blood. 2007;  109(12) 5087-5095
  CrossrefPubMedGoogle Scholar
• 2 Denis C V, Wagner D D. Platelet adhesion receptors and their ligands in mouse models of thrombosis.  Arterioscler Thromb Vasc Biol. 2007;  27(4) 728-739
  CrossrefPubMedGoogle Scholar
• 3 Ruggeri Z M, Mendolicchio G L. Adhesion mechanisms in platelet function.  Circ Res. 2007;  100(12) 1673-1685
  CrossrefPubMedGoogle Scholar
• 4 Sachs U J, Nieswandt B. In vivo thrombus formation in murine models.  Circ Res. 2007;  100(7) 979-991
  CrossrefPubMedGoogle Scholar
• 5 Langer H F, Gawaz M. Platelet-vessel wall interactions in atherosclerotic disease.  Thromb Haemost. 2008;  99(3) 480-486
  PubMedGoogle Scholar
• 6 Franzén L, Dahlquist C. The effect of transforming growth factor-beta on fibroblast cell proliferation in intact connective tissue in vitro.  In Vitro Cell Dev Biol Anim. 1994;  30A(7) 460-463
  PubMedGoogle Scholar
• 7 Klein M B, Yalamanchi N, Pham H, Longaker M T, Chang J. Flexor tendon healing in vitro: effects of TGF-beta on tendon cell collagen production.  J Hand Surg [Am]. 2002;  27(4) 615-620
  PubMedGoogle Scholar
• 8 Centrella M, McCarthy T L, Canalis E. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone.  J Biol Chem. 1987;  262(6) 2869-2874
  PubMedGoogle Scholar
• 9 Harris S E, Bonewald L F, Harris M A et al.. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts.  J Bone Miner Res. 1994;  9(6) 855-863
  CrossrefPubMedGoogle Scholar
• 10 Li Y, Foster W, Deasy B M et al.. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis.  Am J Pathol. 2004;  164(3) 1007-1019
  CrossrefPubMedGoogle Scholar
• 11 Cavins J A, Farber S, Roy A J. Transfusion of fresh platelet concentrates to adult patients with thrombocytopenia.  Transfusion. 1968;  8(1) 24-27
  CrossrefPubMedGoogle Scholar
• 12 Lowenstein L, Weil P G. The treatment of haemorrhage with platelet preserved blood.  Can Serv Med J. 1956;  12(10) 878-882
  PubMedGoogle Scholar
• 13 Matras H. Effect of various fibrin preparations on reimplantations in the rat skin [in German].  Osterr Z Stomatol. 1970;  67(9) 338-359
  PubMedGoogle Scholar
• 14 Carreon L Y, Glassman S D, Anekstein Y, Puno R M. Platelet gel (AGF) fails to increase fusion rates in instrumented posterolateral fusions.  Spine (Phila Pa 1976). 2005;  30 E243-E246
  CrossrefPubMedGoogle Scholar
• 15 Everts P A, Devilee R J, Brown Mahoney C et al.. Exogenous application of platelet-leukocyte gel during open subacromial decompression contributes to improved patient outcome. A prospective randomized double-blind study.  Eur Surg Res. 2008;  40(2) 203-210
  CrossrefPubMedGoogle Scholar
• 16 Uggeri J, Belletti S, Guizzardi S et al.. Dose-dependent effects of platelet gel releasate on activities of human osteoblasts.  J Periodontol. 2007;  78(10) 1985-1991
  CrossrefPubMedGoogle Scholar
• 17 de Mos M, van der Windt A E, Jahr H de MM et al. Can platelet-rich plasma enhance tendon repair? A cell culture study.  Am J Sports Med. 2008;  36(6) 1171-1178
  CrossrefPubMedGoogle Scholar
• 18 Kark L R, Karp J M, Davies J E. Platelet releasate increases the proliferation and migration of bone marrow-derived cells cultured under osteogenic conditions.  Clin Oral Implants Res. 2006;  17(3) 321-327
  CrossrefPubMedGoogle Scholar
• 19 Slater M, Patava J, Kingham K, Mason R S. Involvement of platelets in stimulating osteogenic activity.  J Orthop Res. 1995;  13(5) 655-663
  CrossrefPubMedGoogle Scholar
• 20 Gruber R, Kandler B, Fischer M B, Watzek G. Osteogenic differentiation induced by bone morphogenetic proteins can be suppressed by platelet-released supernatant in vitro.  Clin Oral Implants Res. 2006;  17(2) 188-193
  CrossrefPubMedGoogle Scholar
• 21 Sarkar M R, Augat P, Shefelbine S J et al.. Bone formation in a long bone defect model using a platelet-rich plasma-loaded collagen scaffold.  Biomaterials. 2006;  27(9) 1817-1823
  CrossrefPubMedGoogle Scholar
• 22 Dohan Ehrenfest D M, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).  Trends Biotechnol. 2009;  27(3) 158-167
  CrossrefPubMedGoogle Scholar
• 23 van Hinsbergh V W, Collen A, Koolwijk P. Role of fibrin matrix in angiogenesis.  Ann N Y Acad Sci. 2001;  936 426-437
  CrossrefPubMedGoogle Scholar
• 24 Deasy B M, Lu A, Tebbets J C et al.. A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency.  J Cell Biol. 2007;  177(1) 73-86
  CrossrefPubMedGoogle Scholar
• 25 Anitua E, Sánchez M, Zalduendo M M et al.. Fibroblastic response to treatment with different preparations rich in growth factors.  Cell Prolif. 2009;  42(2) 162-170
  CrossrefPubMedGoogle Scholar
• 26 Virchenko O, Grenegård M, Aspenberg P. Independent and additive stimulation of tendon repair by thrombin and platelets.  Acta Orthop. 2006;  77(6) 960-966
  CrossrefPubMedGoogle Scholar
• 27 Bosch G, van Schie H T, de Groot M W et al.. Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: a placebo-controlled experimental study.  J Orthop Res. 2009;  28(2) 211-217
  PubMedGoogle Scholar
• 28 Schnabel L V, Mohammed H O, Miller B J et al.. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons.  J Orthop Res. 2007;  25(2) 230-240
  CrossrefPubMedGoogle Scholar
• 29 Aspenberg P, Virchenko O. Platelet concentrate injection improves Achilles tendon repair in rats.  Acta Orthop Scand. 2004;  75(1) 93-99
  CrossrefPubMedGoogle Scholar
• 30 Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma.  Am J Sports Med. 2006;  34(11) 1774-1778
  CrossrefPubMedGoogle Scholar
• 31 Lesurtel M, Graf R, Aleil B et al.. Platelet-derived serotonin mediates liver regeneration.  Science. 2006;  312(5770) 104-107
  CrossrefPubMedGoogle Scholar
• 32 Myronovych A, Murata S, Chiba M et al.. Role of platelets on liver regeneration after 90% hepatectomy in mice.  J Hepatol. 2008;  49(3) 363-372
  CrossrefPubMedGoogle Scholar
• 33 Carmeliet P. Angiogenesis in health and disease.  Nat Med. 2003;  9(6) 653-660
  CrossrefPubMedGoogle Scholar
• 34 Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration.  Nat Med. 2003;  9(6) 702-712
  CrossrefPubMedGoogle Scholar
• 35 Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates.  Blood Rev. 2009;  23(4) 177-189
  CrossrefPubMedGoogle Scholar
• 36 Langer H F, Gawaz M. Platelets in regenerative medicine.  Basic Res Cardiol. 2008;  103(4) 299-307
  CrossrefPubMedGoogle Scholar
• 37 Gawaz M, Stellos K, Langer H F. Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells.  J Thromb Haemost. 2008;  6(2) 235-242
  PubMedGoogle Scholar
• 38 Kisucka J, Butterfield C E, Duda D G et al.. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage.  Proc Natl Acad Sci U S A. 2006;  103(4) 855-860
  CrossrefPubMedGoogle Scholar
• 39 Klement G L, Yip T T, Cassiola F et al.. Platelets actively sequester angiogenesis regulators.  Blood. 2009;  113(12) 2835-2842
  CrossrefPubMedGoogle Scholar
• 40 Wartiovaara U, Salven P, Mikkola H et al.. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation.  Thromb Haemost. 1998;  80(1) 171-175
  PubMedGoogle Scholar
• 41 Banks R E, Forbes M A, Kinsey S E et al.. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.  Br J Cancer. 1998;  77(6) 956-964
  CrossrefPubMedGoogle Scholar
• 42 Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine.  Genes Dev. 2008;  22(10) 1276-1312
  CrossrefPubMedGoogle Scholar
• 43 Li J J, Huang Y Q, Basch R, Karpatkin S. Thrombin induces the release of angiopoietin-1 from platelets.  Thromb Haemost. 2001;  85(2) 204-206
  PubMedGoogle Scholar
• 44 O'Reilly M S, Boehm T, Shing Y et al.. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.  Cell. 1997;  88(2) 277-285
  CrossrefPubMedGoogle Scholar
• 45 Maione T E, Gray G S, Petro J et al.. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides.  Science. 1990;  247(4938) 77-79
  CrossrefPubMedGoogle Scholar
• 46 Perollet C, Han Z C, Savona C, Caen J P, Bikfalvi A. Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization.  Blood. 1998;  91(9) 3289-3299
  PubMedGoogle Scholar
• 47 Iruela-Arispe M L, Bornstein P, Sage H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro.  Proc Natl Acad Sci U S A. 1991;  88(11) 5026-5030
  CrossrefPubMedGoogle Scholar
• 48 Kopp H G, Hooper A T, Broekman M J et al.. Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization.  J Clin Invest. 2006;  116(12) 3277-3291
  CrossrefPubMedGoogle Scholar
• 49 Ma L, Elliott S N, Cirino G, Buret A, Ignarro L J, Wallace J L. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release.  Proc Natl Acad Sci U S A. 2001;  98(11) 6470-6475
  CrossrefPubMedGoogle Scholar
• 50 Ma L, Perini R, McKnight W et al.. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets.  Proc Natl Acad Sci U S A. 2005;  102(1) 216-220
  CrossrefPubMedGoogle Scholar
• 51 Italiano Jr J E, Richardson J L, Patel-Hett S et al.. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released.  Blood. 2008;  111(3) 1227-1233
  CrossrefPubMedGoogle Scholar
• 52 D'Amore P, Shepro D. Stimulation of growth and calcium influx in cultured, bovine, aortic endothelial cells by platelets and vasoactive substances.  J Cell Physiol. 1977;  92(2) 177-183
  CrossrefPubMedGoogle Scholar
• 53 Pipili-Synetos E, Papadimitriou E, Maragoudakis M E. Evidence that platelets promote tube formation by endothelial cells on matrigel.  Br J Pharmacol. 1998;  125(6) 1252-1257
  CrossrefPubMedGoogle Scholar
• 54 Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization.  Cardiovasc Res. 2005;  67(1) 30-38
  CrossrefPubMedGoogle Scholar
• 55 Kim H K, Song K S, Chung J H, Lee K R, Lee S N. Platelet microparticles induce angiogenesis in vitro.  Br J Haematol. 2004;  124(3) 376-384
  CrossrefPubMedGoogle Scholar
• 56 Rhee J S, Black M, Schubert U et al.. The functional role of blood platelet components in angiogenesis.  Thromb Haemost. 2004;  92(2) 394-402
  PubMedGoogle Scholar
• 57 Cowan C A, Klimanskaya I, McMahon J et al.. Derivation of embryonic stem-cell lines from human blastocysts.  N Engl J Med. 2004;  350(13) 1353-1356
  CrossrefPubMedGoogle Scholar
• 58 Takahashi K, Tanabe K, Ohnuki M et al.. Induction of pluripotent stem cells from adult human fibroblasts by defined factors.  Cell. 2007;  131(5) 861-872
  CrossrefPubMedGoogle Scholar
• 59 Asahara T, Murohara T, Sullivan A et al.. Isolation of putative progenitor endothelial cells for angiogenesis.  Science. 1997;  275(5302) 964-967
  CrossrefPubMedGoogle Scholar
• 60 Crisan M, Yap S, Casteilla L et al.. A perivascular origin for mesenchymal stem cells in multiple human organs.  Cell Stem Cell. 2008;  3(3) 301-313
  CrossrefPubMedGoogle Scholar
• 61 Zheng B, Cao B, Crisan M et al.. Prospective identification of myogenic endothelial cells in human skeletal muscle.  Nat Biotechnol. 2007;  25(9) 1025-1034
  CrossrefPubMedGoogle Scholar
• 62 Cao B, Zheng B, Jankowski R J et al.. Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential.  Nat Cell Biol. 2003;  5(7) 640-646
  CrossrefPubMedGoogle Scholar
• 63 Sekiguchi H, Ii M, Losordo D W. The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia.  J Cell Physiol. 2009;  219(2) 235-242
  CrossrefPubMedGoogle Scholar
• 64 Hristov M, Zernecke A, Liehn E A, Weber C. Regulation of endothelial progenitor cell homing after arterial injury.  Thromb Haemost. 2007;  98(2) 274-277
  PubMedGoogle Scholar
• 65 Stellos K, Gawaz M. Platelet interaction with progenitor cells: potential implications for regenerative medicine.  Thromb Haemost. 2007;  98(5) 922-929
  PubMedGoogle Scholar
• 66 Stellos K, Gnerlich S, Kraemer B, Lindemann S, Gawaz M. Platelet interaction with progenitor cells: vascular regeneration or inquiry?.  Pharmacol Rep. 2008;  60(1) 101-108
  PubMedGoogle Scholar
• 67 Deasy B M, Jankowski R J, Huard J. Muscle-derived stem cells: characterization and potential for cell-mediated therapy.  Blood Cells Mol Dis. 2001;  27(5) 924-933
  CrossrefPubMedGoogle Scholar
• 68 Qu-Petersen Z, Deasy B, Jankowski R et al.. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration.  J Cell Biol. 2002;  157(5) 851-864
  CrossrefPubMedGoogle Scholar
• 69 Payne T R, Oshima H, Sakai T et al.. Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells.  Gene Ther. 2005;  12(16) 1264-1274
  CrossrefPubMedGoogle Scholar
• 70 Oshima H, Payne T R, Urish K L et al.. Differential myocardial infarct repair with muscle stem cells compared to myoblasts.  Mol Ther. 2005;  12(6) 1130-1141
  CrossrefPubMedGoogle Scholar
• 71 Okada M, Payne T R, Zheng B et al.. Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium.  J Am Coll Cardiol. 2008;  52(23) 1869-1880
  CrossrefPubMedGoogle Scholar
• 72 Carr L K, Steele D, Steele S et al.. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence.  Int Urogynecol J Pelvic Floor Dysfunct. 2008;  19(6) 881-883
  PubMedGoogle Scholar
• 73 Payne T R, Oshima H, Okada M et al.. A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts.  J Am Coll Cardiol. 2007;  50(17) 1677-1684
  CrossrefPubMedGoogle Scholar
• 74 Péault B, Rudnicki M, Torrente Y et al.. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy.  Mol Ther. 2007;  15(5) 867-877
  CrossrefPubMedGoogle Scholar
• 75 Crisan M, Deasy B, Gavina M et al.. Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes.  Methods Cell Biol. 2008;  86 295-309
  PubMedGoogle Scholar
• 76 Collett G D, Canfield A E. Angiogenesis and pericytes in the initiation of ectopic calcification.  Circ Res. 2005;  96(9) 930-938
  CrossrefPubMedGoogle Scholar
• 77 Caplan A I. All MSCs are pericytes?.  Cell Stem Cell. 2008;  3(3) 229-230
  CrossrefPubMedGoogle Scholar
• 78 Langer H F, Stellos K, Steingen C et al.. Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro.  J Mol Cell Cardiol. 2009;  47(2) 315-325
  CrossrefPubMedGoogle Scholar
• 79 Langer H, May A E, Daub K et al.. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro.  Circ Res. 2006;  98(2) e2-e10
  CrossrefPubMedGoogle Scholar
• 80 de Boer H C, Verseyden C, Ulfman L H et al.. Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype.  Arterioscler Thromb Vasc Biol. 2006;  26(7) 1653-1659
  CrossrefPubMedGoogle Scholar
• 81 Langer H F, May A E, Vestweber D, De Boer H C, Hatzopoulos A K, Gawaz M. Platelet-induced differentiation of endothelial progenitor cells.  Semin Thromb Hemost. 2007;  33(2) 136-143
  Article in Thieme ConnectPubMedGoogle Scholar
• 82 Lev E I, Estrov Z, Aboulfatova K et al.. Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix.  Thromb Haemost. 2006;  96(4) 498-504
  PubMedGoogle Scholar
• 83 Zernecke A, Schober A, Bot I et al.. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells.  Circ Res. 2005;  96(7) 784-791
  CrossrefPubMedGoogle Scholar
• 84 Möhle R, Bautz F, Rafii S, Moore M A, Brugger W, Kanz L. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.  Blood. 1998;  91(12) 4523-4530
  PubMedGoogle Scholar
• 85 Peled A, Grabovsky V, Habler L et al.. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow.  J Clin Invest. 1999;  104(9) 1199-1211
  CrossrefPubMedGoogle Scholar
• 86 Stellos K, Gawaz M. Platelets and stromal cell-derived factor-1 in progenitor cell recruitment.  Semin Thromb Hemost. 2007;  33(2) 159-164
  Article in Thieme ConnectPubMedGoogle Scholar
• 87 Massberg S, Konrad I, Schürzinger K et al.. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo.  J Exp Med. 2006;  203(5) 1221-1233
  CrossrefPubMedGoogle Scholar
• 88 Stellos K, Langer H, Daub K et al.. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells.  Circulation. 2008;  117(2) 206-215
  CrossrefPubMedGoogle Scholar
• 89 Jin D K, Shido K, Kopp H G et al.. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes.  Nat Med. 2006;  12(5) 557-567
  CrossrefPubMedGoogle Scholar
• 90 Stellos K, Bigalke B, Langer H et al.. Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells.  Eur Heart J. 2009;  30(5) 584-593
  CrossrefPubMedGoogle Scholar
• 91 Massberg S, Gawaz M, Grüner S et al.. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo.  J Exp Med. 2003;  197(1) 41-49
  CrossrefPubMedGoogle Scholar
• 92 Savage B, Saldívar E, Ruggeri Z M. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.  Cell. 1996;  84(2) 289-297
  CrossrefPubMedGoogle Scholar
• 93 Daub K, Langer H, Seizer P et al.. Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells.  FASEB J. 2006;  20(14) 2559-2561
  CrossrefPubMedGoogle Scholar
• 94 Prokopi M, Pula G, Mayr U et al.. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures.  Blood. 2009;  114(3) 723-732
  CrossrefPubMedGoogle Scholar
• 95 Hill J M, Zalos G, Halcox J P et al.. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.  N Engl J Med. 2003;  348(7) 593-600
  CrossrefPubMedGoogle Scholar
• 96 Werner N, Kosiol S, Schiegl T et al.. Circulating endothelial progenitor cells and cardiovascular outcomes.  N Engl J Med. 2005;  353(10) 999-1007
  CrossrefPubMedGoogle Scholar
• 97 Angiolillo D J, Fernandez-Ortiz A, Bernardo E et al.. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.  Diabetes. 2005;  54(8) 2430-2435
  CrossrefPubMedGoogle Scholar
• 98 Gawaz M, Neumann F J, Ott I, May A, Schömig A. Platelet activation and coronary stent implantation. Effect of antithrombotic therapy.  Circulation. 1996;  94(3) 279-285
  CrossrefPubMedGoogle Scholar
• 99 Dernbach E, Randriamboavonjy V, Fleming I, Zeiher A M, Dimmeler S, Urbich C. Impaired interaction of platelets with endothelial progenitor cells in patients with cardiovascular risk factors.  Basic Res Cardiol. 2008;  103(6) 572-581
  CrossrefPubMedGoogle Scholar
• 100 Möhle R, Green D, Moore M A, Nachman R L, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets.  Proc Natl Acad Sci U S A. 1997;  94(2) 663-668
  CrossrefPubMedGoogle Scholar
• 101 McLaren K M. Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets.  J Clin Pathol. 1983;  36(2) 197-199
  CrossrefPubMedGoogle Scholar
• 102 Brunner G, Nguyen H, Gabrilove J, Rifkin D B, Wilson E L. Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells.  Blood. 1993;  81(3) 631-638
  PubMedGoogle Scholar
• 103 McLaren K M, Pepper D S. Immunological localisation of beta-thromboglobulin and platelet factor 4 in human megakaryocytes and platelets.  J Clin Pathol. 1982;  35(11) 1227-1231
  CrossrefPubMedGoogle Scholar
• 104 Jurasz P, Santos-Martinez M J, Radomska A, Radomski M W. Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis.  J Thromb Haemost. 2006;  4(5) 1095-1106
  CrossrefPubMedGoogle Scholar
• 105 Kaplan D R, Chao F C, Stiles C D, Antoniades H N, Scher C D. Platelet alpha granules contain a growth factor for fibroblasts.  Blood. 1979;  53(6) 1043-1052
  PubMedGoogle Scholar
• 106 Ben-Ezra J, Sheibani K, Hwang D L, Lev-Ran A. Megakaryocyte synthesis is the source of epidermal growth factor in human platelets.  Am J Pathol. 1990;  137(4) 755-759
  PubMedGoogle Scholar
• 107 Villeneuve J, Block A, Le Bousse-Kerdilès M C et al.. Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organization for these secreted proteins.  Exp Hematol. 2009;  37(7) 849-856
  CrossrefPubMedGoogle Scholar
• 108 Karey K P, Sirbasku D A. Human platelet-derived mitogens. II. Subcellular localization of insulinlike growth factor I to the alpha-granule and release in response to thrombin.  Blood. 1989;  74(3) 1093-1100
  CrossrefPubMedGoogle Scholar
• 109 English D, Welch Z, Kovala A T et al.. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis.  FASEB J. 2000;  14(14) 2255-2265
  CrossrefPubMedGoogle Scholar

Konstantinos StellosM.D. 

Medizinische Klinik III, Kardiologie und Kreislauferkrankungen

Eberhard Karls-Universität Tübingen, Tübingen, Germany

Email: konstantinos.stellos@med.uni-tuebingen.de

Harald F LangerM.D. 

Medizinische Klinik III, Kardiologie und Kreislauferkrankungen

Eberhard Karls-Universität Tübingen, 72076 Tubingen, Germany

Email: harald.langer@med.uni-tuebingen.de